Abstract
Sinonasal squamous cell carcinoma (SNSCC) is an aggressive malignancy that has not seen therapeutic advance in decades. Historically attributed to inhaled carcinogens, SNSCC is also incidentally associated with human papillomavirus (HPV), the major oncogenic driver in over 80% of adjacent oropharyngeal cancers. While HPV status guides staging and treatment in oropharyngeal cancer, the oncogenic consequences of host–virus interactions in SNSCC remain incompletely defined. Here, through paired host and viral whole-genome sequencing of 21 cases, we map the genomic footprint of HPV in SNSCC. Strikingly, less-studied genotypes such as HPV45 and 51 constitute driver infections. APOBEC activity was detected in a subset of HPV-associated SNSCC, while Signature 12 emerged as the most frequent dominant mutational signature and showed transcriptional strand bias consistent with an in vivo mutational process. Viral integration events, including extrachromosomal DNA (ecDNA)-associated HPV–human ecDNA amplicons, further contribute to tumor evolution.
Statement of Significance Paired host and viral whole-genome sequencing identifies non-HPV16 high-risk HPV genotypes (e.g., HPV45 and 51) and HPV–human ecDNA amplicons as primary oncogenic drivers of sinonasal squamous cell carcinoma (SNSCC). A distinct mutational landscape, characterized by frequent Signature 12 activity and APOBEC mutagenesis in a subset of tumors, distinguishes SNSCC from other HPV-associated cancers. Importantly, non-HPV16 high-risk HPV genotypes play an underrecognized role in SNSCC, and support their inclusion in routine clinical testing.
Competing Interest Statement
: D.L. Faden: grants from BMS, Calico, and Haystack (Quest); support from Predicine, BostonGene, Neogenomics; fees from Merck, Chrysalis Biomedical Advisors, and Arcadia outside the submitted work; patent 169511-00058-MEEI2024-32 pending. No disclosures were reported by the other authors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRBs of Mass General Brigham and Vanderbilt University Medical Center gave ethical approval for this work. All patients provided written informed consent under protocols approved by both institutions.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵‡ These authors jointly supervised this work.
Authors’ Disclosures: D.L. Faden: grants from BMS, Calico, and Haystack (Quest); support from Predicine, BostonGene, Neogenomics; fees from Merck, Chrysalis Biomedical Advisors, and Arcadia outside the submitted work; patent 169511-00058-MEEI2024-32 pending. No disclosures were reported by the other authors.
This version has been revised to improve consistency, clarity, and focus. The mutational signature analysis has been updated, with corresponding revisions to the methods, results, figures, and interpretation. The authorship and acknowledgments have also been updated.
Data Availability
All data produced in the present work are contained in the manuscript.
